Effect of morphine on lipopolysaccharide-induced tumor necrosis factor-α production in vivo: Involvement of the sympathetic nervous system

Journal of Neuroimmunology

Volumn 73, Issue 1-2, 1997, Pages 1-6

  Bencsics, Agnes ^a   Elenkov, Ilia J ^b   Vizi, E Sylvester ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

in vivo; lipopolysaccharide; morphine; neuroimmunomodulation; norepinephrine; opioid receptors; sympathetic nervous system; tumor necrosis factor alpha

Indexed keywords

LIPOPOLYSACCHARIDE; MORPHINE; NALOXONE; NORADRENALIN; OPIATE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOMODULATION; INFECTION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; LIPOPOLYSACCHARIDES; MALE; MICE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; RECEPTORS, OPIOID; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031058917     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(96)00163-4     Document Type: Article

References (44)

1. Appel, N.M., Kiritsy-Roy, J.A. and Van Loon, G.R. (1984) Hypothalamic opioid peptide regulation of catecholamine secretion. Neuropeptides 5, 287-290.
2. Appel, N.M., Kiritsy-Roy, J.A. and Van Loon, G.R. (1986) Mu receptors at discrete hypothalamic and brainstem sites mediate opioid peptide-induced increases in central sympathetic outflow. Brain Res. 378, 8-20.
3. Barke, K.E. and Hough, L.B. (1993) Opiates, mast cells and histamine release. Life Sci. 53, 1391-1399.
4. Belkowski, S.M., Alicea, A., Eisenstein, T.K., Adler, M.W. and Rogers, T.J. (1995) Inhibition of interleukin-1 and tumor necrosis factor-α synthesis following treatment of macrophages with the kappa opioid agonist U50,488H. J. Pharmacol. Exp. Ther. 273, 1491-1496.
5. Beutler, B. (1995) TNF, immunity and inflammatory disease: lessons of the past decade. J. Invest. Med. 43, 227-235.
6. Beutler, B., Krochin, N., Milsark, I.W., Luedke, C. and Cerami, A. (1984) Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 232, 977-979.
7. Bryant, H.U. and Roudebush, R.E. (1990) Suppressive effect of morphine pellet implants on in vivo parameters of immune function. J. Pharmacol. Exp. Ther. 255, 410-414.
8. Carr, D.J.J., DeCosta, B.R., Kim, C.H., Jacoben, A.E., Rice, K.C. and Blalock, J.E. (1989) Opioid receptors on cells of the immune system: Evidence for delta and kappa classes. J. Endocrinol. 122, 161-168.
9. Carr, D.J.J. (1991) The role of endogenous opioids and their receptors in the immune system. Proc. Soc. Exp. Biol. Med. 198, 710-720.
10. Chao, C.C., Gekker, G., Sheng, W.S., Hu, S., Tsang, M. and Peterson, P.K. (1993a) Priming effect of morphine on the production of tumor necrosis factor-α by microglia: inplications in respiratory burst activity and human immunodeficiency virus-1 expression. J. Pharmacol. Exp. Ther. 269, 198-203.
11. Chao, C.C., Molitor, T.W., Close, K., Hu, S. and Peterson, P.K. (1993b) Morphine inhibits the release of tumor necrosis factor in human peripheral blood mononuclear cell cultures. Int. J. Immunopharmacol. 15, 447-453.
12. Elenkov, I.J. and Vizi, E.S. (1991) Presynaptic modulation of release of noradrenaline from the sympathetic nerve terminals in the rat spleen. Neuropharmacology 30, 1319-1324.
13. Elenkov, I.J., Haskó, G., Kovács, K. and Vizi, E.S. (1995) Modulation of lipopolysaccharide-induced tumor necrosis factor-α production by selective α- and β-adrenergic drugs in mice. J. Neuroimmunol. 61, 123-131.
14. Fecho, K., Dykstra, L.A. and Lysle, D.T. (1993) Evidence for beta adrenergic receptor involvement in the immunomodulatory effects of morphine. J. Pharmacol. Exp. Ther. 265, 1079-1087.
15. Felten, D.L., Felten, S.Y., Carlson, S.L., Olschowka, J.A. and Livnat, S. (1985) Noradrenergic and peptidergic innervation of lymphoid tissue. J. Immunol. 135, 755s-765s.
16. Gatti, S., Faggioni, R., Sironi, M., Erroi, A. and Ghezzi, P. (1993) Mast cells do not contribute to the rapid appearance of TNF in the serum of LPS-treated mice: a study with mast cell-deficient mice. Int. J. Immunopharmacol. 15, 551-555.
17. Gordon, J.R. and Galli, S.J. (1990) Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 346, 274-276.
18. 2-adrenoceptors on plasma levels of tumor necrosis factor-α, interleukin-6 and corticosterone induced by bacterial lipopolysaccharide in mice. J. Endocrinol. 144, 457-462.
19. Haskó, G., Szabó, C., Merkel, K., Bencsics, A., Zingarelli, B., Kvetan, V. and Vizi, E.S. (1996) Modulation of lipopolysaccharide-induced tumor necrosis factor-α and nitric oxide production by dopamine receptor agonists and antagonists in mice. Immunol. Lett. 49, 143-147.
20. Havell, E.A. (1989) Evidence that tumor necrosis factor has an important role in antibacterial resistance. J. Immunol. 143, 2894-2899.
21. Hu, X., Goldmuntz, E.A. and Brosnan, C.F. (1991) The effect of norepinephrine on endotoxin-mediated macrophage activation. J. Neuroimmunol. 31, 35-42.
22. Hubbard, R.L., Marsden, M.E., Cavanaugh, E., Rachal, J.V. and Ginzburg, H.M. (1988) Role of drug-abuse treatment in limiting the spread of AIDS. Rev. Infect. Dis. 10, 377-384.
23. Hussey, H.H. and Katz, S. (1950) Infections resulting from narcotic addiction: Report of 102 cases. Am. J. Med. 9, 186-193.
24. Johnson, H.M., Smith, E.M., Torres, B.A. and Blalock, J.E. (1982) Regulation of the in vitro antibody responses by neuroendocrine hormones. Proc. Natl. Acad. Sci. USA 79, 4171-4174.
25. Louria, D.B., Hensle, T. and Rose, J. (1967) The major medical complications of heroin addiction. Ann. Intern. Med. 67, 1-22.
26. Luttgens, W.F. (1949) Endocarditis in 'main line' opium addicts. Arch. Intern. Med. 83, 653-664.
27. Lysle, D.T., Coussons, M.E., Watts, V.J., Bennett, E.H. and Dykstra, L.A. (1993) Morphine-induced alterations of immune status: Dose-dependency, compartment specificity, and antagonism by naltrexone. J. Pharmacol. Exp. Ther. 265, 1071-1078.
28. Madden, K.S., Sanders, V.M. and Felten, D.L. (1995) Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annu. Rev. Pharmacol. Toxicol. 35, 417-448.
29. Marcoli, M., Ricevoti, G., Mazzone, A., Pasotti, D., Lecchini, S. and Frigo, G.M. (1989) A stereoselective blockade by naloxone by opioid and non-opioid-induced granulocyte activation. Int. J. Immunopharmacol. 11, 57-61.
30. Mestan, J., Digel, W., Mittnacht, S., Hillen, H., Blohm, D., Moller, A., Jacobsen, H. and Kirchner, H. (1986) Antiviral effects of recombinant tumor necrosis factor in vivo. Nature 323, 816-819.
31. Novick, D.M., Ochshorn, M., Ghali, V., Croxson, T.S., Mercer, W.D., Chiorazzi, N. and Kreek, M.J. (1989) Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients. J. Pharmacol. Exp. Ther. 250, 606-610.
32. Peterson, P.K., Sharp, B., Bekker, G., Brummitt, C. and Keane, W.F. (1987) Opioid-mediated suppression of cultured peripheral blood mononuclear cell respiratory burst activity. J. Immunol. 138, 3907-3912.
33. Severn, A., Rapson, N.T., Hunter, C.A. and Liew, F.Y. (1992) Regulation of tumor necrosis factor production by adrenaline and β-adrenergic agonists. J. Immunol. 148, 3441-3445.
34. Shavit, Y., Lewis, J.W., Terman, G.W., Gale, R.P. and Liebeskind, J.C. (1984) Opioid peptides mediate the suppressive effect of stress on natural killer activity. Science 223, 180-190.
35. Shavit, Y., Depaulis, A., Martin, F.C., Terman, G.W., Pechnick, R.N., Cane, C.J., Gale, R.P. and Liebeskind, J.C. (1986) Involvement of brain opioid receptors in the immune-suppressive effect of morphine. Proc. Natl. Acad. Sci. USA 83, 7114-7117.
36. Sibinga, N.E.S. and Goldstein, A. (1988) Opioid peptides and opioid receptors in cells of the immune system. Annu. Rev. Immunol. 6, 219-249.
37. Van der Poll, T., Jansen, J., Endert, E., Sauerwein, H.P. and van Deventer, S.J.H. (1994) Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect. Immun. 62, 2046-2050.
38. Van Loon, G.R., Appel, N.M. and Ho, D. (1981) β-endorphin-induced stimulation of central sympathetic outflow: β-endorphine increases plasma concentrations of epinephrine, norepinephrine, and dopamine in rats. Endocrinology 109, 46-53.
39. 2 receptors. J. Exp. Med. 174, 281-284.
40. Vizi, E.S., Hársing, L.G., Jr., Gaal, J., Kapocsi, J., Bernáth, S. and Somogyi, G.T. (1986) CH-38083, a selective, potent antagonist of alpha-2 adrenoceptors. J. Pharmacol. Exp. Ther. 238, 701-706.
41. Vizi, E.S., Orsó, E., Osipenko, O.N., Haskó, G. and Elenkov, I.J. (1995) Neurochemical, electrophysical and immunocytochemical evidence for a noradrenergic link between the SNS and thymocytes. Neuroscience 68, 1263-1276.
42. Weber, R.J. and Pert, A. (1989) The periaqueductal gray matter mediates opiate-induced immunosuppression. Behav. Neurosci. 102, 534-543.
43. Wong, G.H.W. and Goeddel, D.V. (1986) Tumor necrosis factor alpha and beta inhibit virus replication and synergize with interferons. Nature 323, 819-822.
44. Wybran, J., Appelboom, T., Famey, J.P. and Govaerts, A. (1979) Suggestive evidence for receptors for morphine and methionine enkephalin on normal human blood T-lymphocytes. J. Immunol. 123, 1068-1070.